-
Bioclinica Introduces Expanded and Enhanced ‘SMART’ Technology Suite Available with Medical Imaging, EDC and IRT Combined
Jun 26, 2018, 16:16 PM by Michael CroftPRINCETON, NJ, US - Jun 25, 2018 - Bioclinica®, a global life sciences services provider that utilizes science and technology to bring clarity to clinical trials, today introduces its expanded and enhanced SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC) and Interactive Response Technology (IRT) combinedFull story -
DDN Announces A3I Solutions: Parallel Data Platforms For AI
Jun 26, 2018, 15:40 PM by Michael CroftFull storyBio-IT World Brief | DataDirect Networks today announced a set of data platforms for artificial intelligence and deep learning. Engineered for the AI data center, DDN’s A3I solutions are optimized to handle the spectrum of AI activities concurrently from data ingest and preparation to training, validation and inference.
-
MDI Biological Laboratory Receives $70,000 to Support Organoid Course
Jun 26, 2018, 11:51 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jun 26, 2018 - The MDI Biological Laboratory has announced that it received more than $70,000 in cash and in-kind awards for its inaugural Applications of Organoid Technology course, held May 27 through June 2 on the institutions Bar Harbor campusFull story -
Secure Exchange Solutions Selects Linguamatics NLP to Streamline Inefficiencies between Healthcare Payers and Providers
Jun 26, 2018, 10:35 AM by Michael CroftCAMBRIDGE, UK - Jun 26, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, and Secure Exchange Solutions (SES), a market leader in enabling the secure exchange of health information, today announced the selection of Linguamatics Health as the NLP platform for SES SPOT, a solution that, when combined with SES Fetch, streamlines clinical information exchange and automates the review processFull story -
Rho to Discuss Project Management Best Practices at DIA 2018
Jun 26, 2018, 09:15 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Jun 21, 2018 - WHAT: Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 24-28 in BostonFull story -
New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics
Jun 26, 2018, 04:36 AM by Michael CroftAARHUS, DENMARK - Jun 26, 2018 - Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (Albumedix) have entered into a strategic research collaboration to evaluate the transport properties of albumin for site-selective drug delivery into disease cells to ensure more efficient and safer treatment for patientsFull story -
Deep Learning Tool Empowers Biologists, Speeds Screening
Jun 25, 2018, 13:15 PM by Michael CroftFull storyBio-IT World | Traditional high content screening is labor- and time-intensive, and many groups are working to apply deep learning to image analysis. Genedata worked with AstraZeneca to validate a deep learning workflow tool for biologists that can be “unsupervised”—it works without re-engineering across different assay types and settings.
-
Orion Contract Manufacturing enters supply agreement with Peptonic Medical
Jun 25, 2018, 08:20 AM by Michael CroftESPOO, FINLAND - Jun 25, 2018 - Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital®Full story -
Darren Beckinsale joins The RSA Group as Consultant
Jun 25, 2018, 05:57 AM by Michael CroftOXFORD, UK - Jun 25, 2018 - The RSA Group, a leading Life Sciences executive search firm, announced today that Darren Beckinsale has joined the firm as a ConsultantFull story -
David Venables wins the Disruptor category of EY Entrepreneur Of The Year 2018, Scotland
Jun 22, 2018, 08:13 AM by Michael CroftEDINBURGH, UK - Jun 22, 2018 - Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the Disruptor category of Scotlands EY Entrepreneur Of The Year 2018Full story -
Challenges In Bringing Personalized Cancer Vaccines To The Clinic
Jun 21, 2018, 09:20 AM by Michael CroftFull storyBio-IT World Contributed Commentary | The cancer vaccine industry faces a challenge: How to transition from prediction to effective vaccine therapy?
-
Equus Compute Solutions Announces Release of WHITEBOX OPEN™ Server Platforms Open-hardware solutions provide freedom of choice
Jun 20, 2018, 10:09 AM by Michael CroftEDINA, MN, UNITED STATES - Jun 20, 2018 - Equus Compute Solutions announces the release of its WHITEBOX OPEN family of servers and storage solutions that are custom, cost-optimized open-hardware platformsFull story -
Preclinical PET-MR Workshop brings multi-modality imaging to life
Jun 20, 2018, 09:47 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jun 20, 2018 - Preclinical PET-MR Workshop brings multi-modality imaging to life An interactive preclinical PET-MR workshop with demonstrations of a new 7T integrated PET-MR multi-modality imaging system from MR Solutions and presentations from participants was held in Dijon last weekFull story -
Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis
Jun 20, 2018, 09:40 AM by Michael CroftFull storyBio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.
-
Sartorius Stedim Biotech and Siemens sign long-term cooperation agreement in the area of automation
Jun 20, 2018, 09:37 AM by Michael Croft, GERMANY - Jun 20, 2018 - • Siemens becomes a preferred supplier for automation solutions • Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future • New automated product to debut at the ACHEMA 2018 trade show in Frankfurt Göttingen | Munich - The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automationFull story -
Creative Biolabs Will Continue to Enrich the Phage Display Library Service Items
Jun 19, 2018, 22:37 PM by Michael CroftSHIRLEY, NY - Jun 19, 2018 - June 19, 2018, with the commitment of deliver the highest quality results and rich service items to our clients with speed, Creative Biolabs is going to enrich its phage display library which is recognized as the most powerful and widely used technique for the study of protein-protein, protein-DNA and protein-peptides interactionsFull story -
Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access
Jun 19, 2018, 12:21 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Jun 19, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced it has partnered with Lyft, to deliver a seamless experience for site coordinators to book a ride and execute a reimbursement or stipend for clinical trial participants within its industry-leading ClinCard solutionFull story -
Creative Diagnostics Continues to Expand Its Offering with New Nanoclusters
Jun 19, 2018, 10:48 AM by Michael CroftSHIRLEY - Jun 19, 2018 - With years of experience in the pharmaceutical and life science sector, Creative Diagnostics recently launches Nanclusters, which are functionalized with carboxyl groups that allow the covalent conjugation of antibodies by formation of stable amide bonds with primary aminesFull story -
LBRN Summer Bioinformatics Training Program
Jun 19, 2018, 10:39 AM by Michael CroftNEW ORLEANS, LA, UNITED STATES - Jun 19, 2018 - Pine Biotech and Louisiana Biomedical Research Network (LBRN) announce the registration for its upcoming Louisiana Biomedical Research Network Summer Bioinformatics Training Program which starts June 6 continue through August 15, 2018Full story -
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Jun 19, 2018, 09:42 AM by Michael CroftReuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.Full story